Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
Go back to Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026| (NASDAQ: KYMR) | Delayed: 99.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.45 | 52 Week High | $ | |||
| Open | $99.45 | 52 Week Low | $ | |||
| Day High | $99.45 | P/E | N/A | |||
| Day Low | $99.45 | EPS | $ | |||
| Volume | 373 | |||||
